Sai Parenterals Limited

Sai Parenterals Limited (SAIPARENT) is a micro-cap Healthcare company valued at ₹2,152 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Sai Parenterals Limited last traded at ₹487.9, modestly up 0.83% on the day.

Recent developments

On 2026-08-12, Sai Parenterals reported a strong Q1 FY27, with revenue hitting ₹182 crore and PAT jumping 464% year-over-year. This marks an important milestone as profitability improves and margins begin to recover on an enlarged business base.

Financial performance

The company's business has grown significantly, with annual revenue rising 133.7% year-over-year. The latest quarter saw revenue surge 435.1% compared to the same quarter a year earlier, and net profit jumped 457.7% to ₹8 crore. However, the net profit margin has dropped 4.8 percentage points to 3.7%, and return on equity remains low at 2.9%.

Valuation multiples

The stock trades at 151.1 times earnings, a premium to the Healthcare median of 32.0, 4.70 times book value.

Things to watch

The company's net profit margin has fallen sharply to 3.7%, down 4.8 percentage points from the prior year. Domestic institutional holdings dropped 4.33 percentage points in the quarter, and foreign institutional holdings fell 1.70 percentage points. The stock is 25.8% below its 52-week high.

Where it stands

Sai Parenterals has delivered strong revenue growth, with the latest quarter showing a 435.1% increase in revenue and a 457.7% rise in net profit. However, the net profit margin has declined significantly, and the stock is trading 25.8% below its 52-week high. The company's return on equity remains low at 2.9%.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.